Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to elucidate whether the individualized medicine based on NAT2 gene polymorphism could improve the safety, efficacy and economical benefits of multi-drug therapy for the pulmonary tuberculosis with isoniazid.


Options:
A: Arm Label: BIBW 2992; Type: EXPERIMENTAL; Interventions: Drug: BIBW 2992 | Arm Label: Cisplatin/Pemetrexed; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pemetrexed, Drug: Cisplatin | Intervention Type: DRUG; Name: Pemetrexed; Assigned to Arm(s): Cisplatin/Pemetrexed | Intervention Type: DRUG; Name: BIBW 2992; Assigned to Arm(s): BIBW 2992 | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): Cisplatin/Pemetrexed
B: Arm Label: PGx-treatment; Type: EXPERIMENTAL; Interventions: Drug: Isoniazid | Arm Label: STD-treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: isoniazed | Intervention Type: DRUG; Name: Isoniazid; Assigned to Arm(s): PGx-treatment | Intervention Type: DRUG; Name: isoniazed; Assigned to Arm(s): STD-treatment
C: Intervention Type: DRUG; Name: Abacavir; Assigned to Arm(s): N/A
D: Arm Label: non taxane based chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Biological: filgrastim, Drug: cyclophosphamide, Drug: epirubicin hydrochloride, Drug: fluorouracil, Genetic: microarray analysis, Other: immunohistochemistry staining method, Other: laboratory biomarker analysis, Procedure: biopsy, Procedure: conventional surgery, Procedure: neoadjuvant therapy, Radiation: radiation therapy | Arm Label: taxane based chemotherapy; Type: EXPERIMENTAL; Interventions: Drug: docetaxel, Drug: epirubicin hydrochloride, Genetic: microarray analysis, Other: immunohistochemistry staining method, Other: laboratory biomarker analysis, Procedure: biopsy, Procedure: conventional surgery, Procedure: neoadjuvant therapy, Radiation: radiation therapy | Intervention Type: BIOLOGICAL; Name: filgrastim; Assigned to Arm(s): non taxane based chemotherapy | Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): non taxane based chemotherapy | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): taxane based chemotherapy | Intervention Type: DRUG; Name: epirubicin hydrochloride; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: DRUG; Name: fluorouracil; Assigned to Arm(s): non taxane based chemotherapy | Intervention Type: GENETIC; Name: microarray analysis; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: OTHER; Name: immunohistochemistry staining method; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: OTHER; Name: laboratory biomarker analysis; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: PROCEDURE; Name: biopsy; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: PROCEDURE; Name: conventional surgery; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: PROCEDURE; Name: neoadjuvant therapy; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): non taxane based chemotherapy, taxane based chemotherapy

Answer: B